Valuation: IRIDEX Corporation

Market Cap 11.07M 9.72M 9.17M 8.36M 15.65M 1.06B 15.76M 110M 42.43M 541M 41.54M 40.65M 1.74B P/E 2026 *
-5.21x
P/E 2027 * -
Enterprise Value 11.07M 9.72M 9.17M 8.36M 15.65M 1.06B 15.76M 110M 42.43M 541M 41.54M 40.65M 1.74B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.2x
Free-Float
61.09%
Yield 2026 *
-
Yield 2027 * -
1 day-0.79%
1 week-4.10%
Current month-13.63%
1 month-16.26%
3 months-47.48%
6 months-53.70%
Current year-45.18%
1 week 0.62
Extreme 0.6202
0.67
1 month 0.61
Extreme 0.607
0.74
Current year 0.61
Extreme 0.607
1.65
1 year 0.61
Extreme 0.607
1.65
3 years 0.61
Extreme 0.607
3.65
5 years 0.61
Extreme 0.607
9.46
10 years 0.61
Extreme 0.607
16.39
Manager TitleAgeSince
Chief Executive Officer 54 2024-09-30
Director of Finance/CFO 68 2018-12-17
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 2020-06-23
Director/Board Member 54 2018-08-31
Director/Board Member 66 2022-03-16
Date Insider Type Main position Quantity % Market Cap. Importance
9/16/26 Buy

Chief Financial Officer

7,900 0.0450%
9/14/26 Buy

Chief Financial Officer

2,354 0.0134%
9/10/26 Buy

Chief Financial Officer

5,100 0.0290%
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%-4.10%-47.48%-71.59% 11.07M
-0.50%+2.53%+44.23%+34.25% 251B
+0.32%+5.64%+20.75%-9.61% 157B
+1.42%+5.64%-8.74%+40.59% 141B
-1.70%+0.85%-55.21%-18.06% 64.75B
+0.65%-2.22%+15.58%+23.87% 49.41B
+1.56%-1.64%-18.61%-20.39% 47.09B
-0.03%+10.52%+38.92%+55.09% 48.73B
+0.75%+0.89%+48.14%+61.17% 42.28B
-1.42%+10.12%+185.99%+103.87% 41.36B
Average -0.12%+2.50%+22.36%+19.92% 84.29B
Weighted average by Cap. -0.31%+3.46%+24.99%+25.42%

Financials

2026 *2027 *
Net sales 52.52M 46.11M 43.5M 39.66M 74.27M 5.03B 74.78M 521M 201M 2.57B 197M 193M 8.26B 55.98M 49.15M 46.37M 42.27M 79.16M 5.36B 79.71M 555M 215M 2.74B 210M 206M 8.8B
Net income -2.09M -1.83M -1.73M -1.58M -2.95M -200M -2.97M -20.68M -8M -102M -7.83M -7.66M -328M 1K 877.96 828.3 755.17 1.41K 95.8K 1.42K 9.91K 3.83K 48.93K 3.75K 3.67K 157K
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
26-09-25 US$0.6250 -0.79% 27,842
26-09-24 US$0.6300 -0.63% 34,844
26-09-23 US$0.6340 -0.24% 17,537
26-09-22 US$0.6355 -1.17% 12,075
26-09-21 US$0.6430 -4.03% 46,131
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6250USD
Average target price
2.750USD
Spread / Average Target
+340.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock